RxDoctor Payments Data

Alberto Martinez, MD

Family Medicine · Gonzales, CANPI 1174768816

Payments from drug & device makers

$4,965in general payments, 2019–2025

Across 287 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$640
  • Pfizer$458
  • Lilly USA, LLC$444
  • Abbott$376
  • Novo Nordisk$274
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$4,941100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,965 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$304,653
Medicare patients
902
Services billed
6,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin369$400,127
TrulicityDulaglutide124$187,736
MounjaroTirzepatide49$52,161
EliquisApixaban54$48,094
OzempicSemaglutide37$47,828
JanuviaSitagliptin Phosphate27$39,327
SantylCollagenase Clostridium Hist.18$32,288
Rosuvastatin Calcium814$26,527
FarxigaDapagliflozin Propanediol20$22,774
Repatha SureclickEvolocumab20$21,336
TradjentaLinagliptin23$21,140
LinzessLinaclotide16$16,088
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$15,777
Atorvastatin Calcium1,200$15,443
Breo ElliptaFluticasone/Vilanterol39$15,355

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$71$421,267392 claims
Lilly USA, LLCTrulicity, Mounjaro$444$239,898173 claims
PfizerEliquis$458$48,09454 claims
Novo NordiskOzempic$274$47,82837 claims
MerckJanuvia$26$39,32727 claims
Smith+NephewSantyl$129$32,28818 claims
GSKTrelegy Ellipta, Breo Ellipta$239$31,13253 claims
AstraZenecaFarxiga$206$22,77420 claims
AbbVieLinzess$1,276$16,08816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Gonzales

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →